Loading company
Loading
Open Financials YD Bio Ltd (YDES) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $596,817 | $510,360 | +16.9% | 20-F 2026-04-30 · proof |
| Gross profit | $167,410 | $155,356 | +7.8% | 20-F 2026-04-30 · proof |
| Operating income | -$5.3 million | -$1.5 million | 20-F 2026-04-30 · proof | |
| Net income | -$8.3 million | -$1.4 million | 20-F 2026-04-30 · proof | |
| Cash from operating activities | -$6.6 million | -$1.2 million | 20-F 2026-04-30 · proof | |
| Free cash flow | -$8 million | -$1.3 million | 20-F 2026-04-30 · proof | |
| Total assets | $13.8 million | $6.9 million | +100.7% | 20-F 2026-04-30 · proof |
| Total liabilities | $16.6 million | $273,980 | +5,971.6% | 20-F 2026-04-30 · proof |
| Cash and cash equivalents | $6 million | $3.1 million | +91.8% | 20-F 2026-04-30 · proof |
- What was YD Bio Ltd (YDES)'s revenue in fiscal 2025?
- YD Bio Ltd (YDES) reported revenue of $596,817 for fiscal 2025 (the year ended Dec 31, 2025), against $510,360 the year before (+16.9%). Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What was YD Bio Ltd (YDES)'s gross profit in fiscal 2025?
- YD Bio Ltd (YDES) reported gross profit of $167,410 for fiscal 2025 (the year ended Dec 31, 2025), against $155,356 the year before (+7.8%). Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What was YD Bio Ltd (YDES)'s operating income in fiscal 2025?
- YD Bio Ltd (YDES) reported operating income of -$5.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.5 million the year before. Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What was YD Bio Ltd (YDES)'s net income in fiscal 2025?
- YD Bio Ltd (YDES) reported net income of -$8.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.4 million the year before. Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What was YD Bio Ltd (YDES)'s cash from operating activities in fiscal 2025?
- YD Bio Ltd (YDES) reported cash from operating activities of -$6.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.2 million the year before. Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What was YD Bio Ltd (YDES)'s free cash flow in fiscal 2025?
- YD Bio Ltd (YDES) reported free cash flow of -$8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.3 million the year before. Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What are YD Bio Ltd (YDES)'s total assets?
- As of Dec 31, 2025, YD Bio Ltd (YDES) reported total assets of $13.8 million, against $6.9 million a year earlier (+100.7%). Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What are YD Bio Ltd (YDES)'s total liabilities?
- As of Dec 31, 2025, YD Bio Ltd (YDES) reported total liabilities of $16.6 million, against $273,980 a year earlier (+5,971.6%). Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
- What are YD Bio Ltd (YDES)'s cash and cash equivalents?
- As of Dec 31, 2025, YD Bio Ltd (YDES) reported cash and cash equivalents of $6 million, against $3.1 million a year earlier (+91.8%). Source: the 20-F filed with the SEC on Apr 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:YDES&period_type=annual&limit=5"Information only, not investment advice.